This course is expiring, etc. etc. etc.
CE Credit Hours: 2.00 Continuing Education Credit Hours
CEU Course Description
Cancer is a leading cause of burden of disease globally. Although exercise is an effective treatment for many chronic diseases, it is important to know how much exercise can be safely tolerated in the immune-compromised population of people with cancer. The goal of this CEU course is to investigate if there is a dose-response effect of exercise on inflammation and fatigue in adult cancer survivors, and if there is a dose-response effect of exercise for improving functional activity in this population. This course is based on an article by the Elsevier Journal of Physiotherapy.
CEU Course Objectives
CEU Course Syllabus
|Introduction||0.15 Contact Hours|
|Research Comparison Methods||0.15 Contact Hours|
|Systematic Review Results||0.46 Contact Hours|
|Adverse Effects and Adherence||0.46 Contact Hours|
|Health Outcomes||0.32 Contact Hours|
|Discussion and Conclusion||0.46 Contact Hours|
Total = 2 Contact Hours
Instructional level: Basic
Did you know you can now get UNLIMITED Continuing Education Credit Hours for only $95/year?
Click Here to learn more.
We will disclose, in advance, any proprietary interest in any product, instrument, device, service, or material to be discussed during the learning event, as well as the source of any third-party compensation related to the presentation. This policy applies to both our organization and contractors. If such proprietary/financial interests exist, we will publish a disclaimer in marketing or instructional materials for a course.
In order to view this course, you will need to be able to view a PDF document for the course material. If your device doesn't have the capability to view a PDF, you can click here to download Adobe Acrobat for free.
The board approval status information is provided based on our current understanding of the licensing agencies. Please note that it is the responsibility of each licensee to verify acceptance of our courses with their licensing agency.